Efficacy and safety of tribendimidine against clonorchis sinensis

Clinical Infectious Diseases

Volumn 56, Issue 7, 2013, Pages

  Qian, Men Bao ^a   Yap, Peiling ^b,d   Yang, Yi Chao ^e   Liang, Hai ^f   Jiang, Zhi Hua ^e   Li, Wei ^f   Tan, Yu Guang ^e   Zhou, Hui ^c,d   Utzinger, Jürg ^b,d   Zhou, Xiao Nong ^a   Keiser, Jennifer ^c,d  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Department of Epidemiology and Public Health ^*  (Switzerland)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

^e GUANGXI CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f Binyang Center for Disease Control and Prevention   (China)

Author keywords

Clonorchiasis; Clonorchis sinensis; People's Republic of China; Praziquantel; Tribendimidine

Indexed keywords

ANTITREMATODAL AGENT; PRAZIQUANTEL; TRIBENDIMIDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINA; CLONORCHIASIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FECES CULTURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARASITE IDENTIFICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; VOMITING;

ADULT; ANIMALS; ANTHELMINTICS; CHINA; CLONORCHIASIS; CLONORCHIS SINENSIS; DRUG TOXICITY; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARASITE EGG COUNT; PHENYLENEDIAMINES; PRAZIQUANTEL; TREATMENT OUTCOME;

EID: 84875036535     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis1011     Document Type: Article

References (30)

1. Fürst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 210-221.
2. Fürst T, Sayasone S, Odermatt P, Keiser J, Utzinger J. Manifestation, diagnosis, and management of foodborne trematodiasis. BMJ 2012; 344:e4093.
3. Hong ST, Fang Y. Clonorchis sinensis and clonorchiasis, an update. Parasitol Int 2012; 61: 17-24.
4. Choi MH, Park SK, Li Z, et al. Effect of control strategies on prevalence, incidence and re-infection of clonorchiasis in endemic areas of China. PLoS Negl Trop Dis 2010; 4:e601.
5. Rim HJ. The current pathobiology and chemotherapy of clonorchiasis. Korean J Parasitol 1986; 24: 1-141.
6. Keiser J, Xiao SH, Chollet J, Tanner M, Utzinger J. Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini. Antimicrob Agents Chemother 2007; 51: 1096-8.
7. Xiao SH, Xue J, Xu LL, Zheng Q, Qiang HQ, Zhang YN. The in vitro and in vivo effect of tribendimidine and its metabolites against Clonorchis sinensis. Parasitol Res 2009; 105: 1497-507.
8. Soukhathammavong P, Odermatt P, Sayasone S, et al. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. Lancet Infect Dis 2011; 11: 110-8.
9. Keiser J, Utzinger J. The drugs we have and the drugs we need against major helminth infections. Adv Parasitol 2010; 73: 197-230.
10. Olliaro P, Seiler J, Kuesel A, et al. Potential drug development candidates for human soil-transmitted helminthiases. PLoS Negl Trop Dis 2011; 5:e1138.
11. Xiao SH, Wu ZX, Zhang JH, et al. Clinical observation on 899 children infected with intestinal nematodes and treated with tribendimidine enteric coated tablets. Chin J Parasitol Parasit Dis 2007; 25: 372-5 [in Chinese].
12. Zhang JH, Xiao SH, Wu ZX, et al. Tribendimidine enteric coated tablet in treatment of 1,292 cases with intestinal nematode infection - a phase IV clinical trial. Chin J Parasitol Parasit Dis 2008; 26: 6-9 [in Chinese].
13. Wu ZX, Fang YY, Liu YS. Effect of a novel drug - enteric coated tribendimidine in the treatment of intestinal nematode infections. Chin J Parasitol Parasit Dis 2006; 24: 23-6 [in Chinese].
14. Julious S. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 2005; 4: 287-91.
15. Cancer Therapy Evaluation Program. Common Toxicity Criteria, Version 2.0. DCTD, NCI, NIH, DHHS 1998.
16. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop São Paulo 1972; 14: 397-400.
17. Yu SH, Kawanaka M, Li XM, Xu LQ, Lan CG, Rui L. Epidemiological investigation on Clonorchis sinensis in human population in an area of South China. Jpn J Infect Dis 2003; 56: 168-71.
18. Lun ZR, Gasser RB, Lai DH, et al. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis 2005; 5: 31-41.
19. Dakshanamurthy S, Issa NT, Assefnia S, et al. Predicting new indications for approved drugs using a proteochemometric method. J Med Chem 2012; 55: 6832-6848.
20. Keiser J, Utzinger J. Antimalarials in the treatment of schistosomiasis. Curr Pharm Des 2012; 18: 3531-8.
21. Rim HJ, Lyu KS, Lee JS, Joo KH. Clinical evaluation of the therapeutic efficacy of praziquantel (Embay 8440) against Clonorchis sinensis infection in man. Ann Trop Med Parasitol 1981; 75: 27-33.
22. Rim HJ, Lee YM, Lee JS, Joo KH. Therapeutic field trial with praziquantel (Biltricide®) in a rural population infected with Clonorchis sinensis. Korean J Parasitol 1982; 20: 1-8.
23. Rim HJ, Park CY, Lee JS, Joo KH, Lyu KS. Therapeutic effects of praziquantel (Embay 8440) against Hymenolepis nana infection. Korean J Parasitol 1978; 16: 82-7.
24. WHO. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization, 2006.
25. Augusto G, Magnussen P, Kristensen TK, Appleton CC, Vennervald BJ. The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique. Parasitology 2009; 136: 1771-9.
26. Kim CH, Lee JK, Chung BS, Li S, Choi MH, Hong ST. Influencing factors for cure of clonorchiasis by praziquantel therapy: infection burden and CYP3A5 gene polymorphism. Korean J Parasitol 2011; 49: 45-9.
27. Tatonova YV, Chelomina GN, Besprosvannykh VV. Genetic diversity of nuclear ITS1-5.8S-ITS2 rDNA sequence in Clonorchis sinensis Cobbold, 1875 (Trematoda: Opisthorchidae) from the Russian Far East. Parasitol Int 2012; 61: 664-74.
28. Tinga N, De N, Vien HV, et al. Little effect of praziquantel or artemisinin on clonorchiasis in northern Vietnam. A pilot study. Trop Med Int Health 1999; 4: 814-8.
29. Utzinger J, Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother 2004; 5: 263-85.
30. WHO. Report of the WHO expert consultation on foodborne trematode infections and taeniasis/cysticercosis. Vientiane: World Health Organization, 2011.